methoxyhydroxyphenylglycol has been researched along with Cognitive Dysfunction in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Jacobs, HIL; Riphagen, JM; van Egroo, M | 1 |
Aerts, T; De Deyn, PP; Fransen, E; Gerritsen, MJ; Spikman, JM; Van Dam, D; van der Zee, S; van Laar, T; Vermeiren, Y | 1 |
2 other study(ies) available for methoxyhydroxyphenylglycol and Cognitive Dysfunction
Article | Year |
---|---|
Elevated Norepinephrine Metabolism Gauges Alzheimer's Disease-Related Pathology and Memory Decline.
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Cognitive Dysfunction; Cohort Studies; Disease Progression; Female; Humans; Learning; Locus Coeruleus; Male; Memory Disorders; Methoxyhydroxyphenylglycol; Middle Aged; Neuropsychological Tests; Norepinephrine; Predictive Value of Tests; tau Proteins | 2021 |
Monoaminergic Markers Across the Cognitive Spectrum of Lewy Body Disease.
Topics: Aged; Biogenic Monoamines; Biomarkers; Cognition Disorders; Cognitive Dysfunction; Diagnosis, Differential; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Lewy Body Disease; Male; Methoxyhydroxyphenylglycol; Middle Aged; Parkinson Disease; Retrospective Studies | 2018 |